Robert W. Musslewhite - 16 Feb 2023 Form 4 Insider Report for Definitive Healthcare Corp. (DH)

Role: Chief Executive Officer, Director
Signature: /s/ Matthew Ruderman, as attorney in fact
Issuer symbol: DH
Transactions as of: 16 Feb 2023
Net transactions value: $0
Form type: 4
Filing time: 21 Feb 2023, 15:31:11 UTC
Previous filing: 10 Jan 2023
Next filing: 11 Apr 2023
SEC: View on sec.gov

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	DH	Class A Common Stock	Award	$0	+368,422	+38%	$0.000000	1,350,393	16 Feb 2023	Direct	F1

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	Represents restricted stock units ("RSUs"), each representing a contingent right to receive one share of the Issuer's Class A Common Stock, par value $0.001. The RSUs vest over a four-year period, with 25% of the RSUs vesting on February 1, 2024, followed by quarterly vesting of 6.25% every three months thereafter over the subsequent three years, in each case subject to the Reporting Person's continued service with the Issuer through each such vesting date.

Content

Represents restricted stock units ("RSUs"), each representing a contingent right to receive one share of the Issuer's Class A Common Stock, par value $0.001. The RSUs vest over a four-year period, with 25% of the RSUs vesting on February 1, 2024, followed by quarterly vesting of 6.25% every three months thereafter over the subsequent three years, in each case subject to the Reporting Person's continued service with the Issuer through each such vesting date.